112 related articles for article (PubMed ID: 22355994)
1. Correlation of Ki 67 proliferative index with clinical and pathological features on tissue sections of non Hodgkins lymphoma by immunostaining.
Naz E; Mirza T; Aziz S; Ali A; Danish F
J Pak Med Assoc; 2011 Aug; 61(8):748-52. PubMed ID: 22355994
[TBL] [Abstract][Full Text] [Related]
2. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
3. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
4. Classifying B-cell non-Hodgkin lymphoma by using MIB-1 proliferative index in fine-needle aspirates.
Ali AE; Morgen EK; Geddie WR; Boerner SL; Massey C; Bailey DJ; da Cunha Santos G
Cancer Cytopathol; 2010 Jun; 118(3):166-72. PubMed ID: 20544708
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
6. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
[TBL] [Abstract][Full Text] [Related]
8. A comparison of Ki67 immunostaining and nucleolar organiser region staining in non-Hodgkin's lymphoma. P. A. Hall, J. Crocker, A. Watts, A. G. Stansfeld. Histopathology 1988; 12; 373-381 & Detection of the Ki67 antigen in fixed and wax embedded sections with the monoclonal antibody MIB1.D. McCormick, H. Chong, C. Hobbs, C. Datta &P. A. Hall. Histopathology 1993; 22; 355-360.
Hall PA
Histopathology; 2002 Sep; 41(3A):111-4; discussion 114. PubMed ID: 12405939
[No Abstract] [Full Text] [Related]
9. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
[TBL] [Abstract][Full Text] [Related]
10. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
[TBL] [Abstract][Full Text] [Related]
12. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Ki67 proliferative indices among WHO subtypes of non-Hodgkin's lymphoma: association with other clinical parameters.
Hashmi AA; Hussain ZF; Faridi N; Khurshid A
Asian Pac J Cancer Prev; 2014; 15(20):8759-63. PubMed ID: 25374203
[TBL] [Abstract][Full Text] [Related]
14. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
15. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 proliferative marker in lymph node aspirates of patients with non-Hodgkin's lymphoma.
Mihaljević B; Nedeljkov-Janćić R; Cemerikić-Martinović V; Babić D; Colović M
Med Oncol; 2006; 23(1):83-89. PubMed ID: 16645233
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic study of Ki-67 proliferation index in colorectal carcinoma.
Ahmed NY; Ismail AT; Kareem TS
Saudi Med J; 2012 Aug; 33(8):841-5. PubMed ID: 22886115
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotyping of Non-Hodgkin's lymphomas in Sudan.
Hamid KH; Elduma AH; Mohamed BM; Salih MM
Pan Afr Med J; 2014; 18():82. PubMed ID: 25400849
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinicopathologic correlation of different types of non Hodgkin's lymphoma according to WHO classification.
Naz E; Mirza T; Aziz S; Danish F; Siddiqui ST; Ali A
J Pak Med Assoc; 2011 Mar; 61(3):260-3. PubMed ID: 21465941
[TBL] [Abstract][Full Text] [Related]
20. [The expression and clinical significance of proliferative antigen Ki-67 and apoptosis-antagonizing antigen Bcl-2 in non-Hodgkin's lymphoma].
Xu W; Sheng R; Zheng Z; Xu T
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):452-5. PubMed ID: 11798613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
